Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL)

被引：1
|
作者：
Li, He [1 ]
Zhang, Wanhua [1 ]
Yi, Dongni [1 ]
Ye, Yuanxin [2 ]
Xiao, Xueqiu [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Hematol Res Lab, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR-ABL; CLINICAL IMPACT; IMATINIB; RESISTANT; THERAPY;
D O I：
10.1080/10428194.2016.1225205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1007
页数：3
相关论文
共 50 条
  • [1] Ultrasensitive Duplex Sequencing of Pretreatment ABL1 Kinase Domain Mutations in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Sasaki, Koji
    Ravandi, Farhad
    Cortes, Jorge E.
    Konopleva, Marina Y.
    Issa, Ghayas C.
    Kanagal-Shamanna, Rashmi
    Kornblau, Steven M.
    Garcia-Manero, Guillermo
    Rivera, Victor
    Garris, Rebecca E.
    Salk, Jesse
    Prichard, Justin
    Radich, Jerald P.
    Jabbour, Elias J.
    BLOOD, 2018, 132
  • [2] Duplex Sequencing Identifies Low Level ABL1 Kinase Domain Mutations in Untreated Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Short, Nicholas
    Kantarjian, Hagop
    Sasaki, Koji
    Kanagal-Shamanna, Rashmi
    Ravandi, Farhad
    Cortes, Jorge
    Konopleva, Marina
    Issa, Ghayas
    Kornblau, Steven
    Garcia-Manero, Guillermo
    Rivera, Victor
    Garris, Rebecca
    Salk, Jesse
    Prichard, Justin
    Radich, Jerald
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S186 - S186
  • [3] BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
    Andolina, Jeffrey R.
    ACTA HAEMATOLOGICA, 2015, 134 (02) : 69 - 70
  • [4] Ultra-Accurate Assessment of Pretreatment ABL1 Kinase Domain (KD) Mutations in Patients (pts) with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Using Duplex Sequencing (DS)
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Kanagal-Shamanna, Rashmi
    Sasaki, Koji
    Ravandi, Farhad
    Cortes, Jorge E.
    Konopleva, Marina Y.
    Issa, Ghayas C.
    Kornblau, Steven M.
    Garcia-Manero, Guillermo
    Rivera, Victor
    Garris, Rebecca
    Higgins, Jacob
    Pratt, Gabriel
    Williams, Lindsey N.
    Valentine, Charles C.
    Salk, Jesse J.
    Prichard, Justin
    Radich, Jerald P.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [5] CLINICAL IMPACT OF ABL1 KINASE AND IKZF1 MUTATIONS IN ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): MOLECULAR ANALYSIS OF CALGB 10001 AND 9665 (ALLIANCE)
    DeBoer, R.
    Mulkey, F.
    Koval, G.
    Wetzler, M.
    Marcucci, G.
    Stone, R. M.
    Larson, R. A.
    Geyer, S.
    Mullighan, C.
    Stock, W.
    HAEMATOLOGICA, 2014, 99 : 258 - 258
  • [6] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Konopleva, Marina Y.
    Khouri, Rita
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Nunez, Cesar
    Kadia, Tapan M.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [7] Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
    DeBoer, Rebecca
    Koval, Gregory
    Mulkey, Flora
    Wetzler, Meir
    Devine, Steven
    Marcucci, Guido
    Stone, Richard M.
    Larson, Richard A.
    Bloomfield, Clara D.
    Geyer, Susan
    Mullighan, Charles G.
    Stock, Wendy
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2298 - 2306
  • [8] Discovery of a Selective PROTAC Degrading Untamable BCR::ABL1 Compound Mutants in Chronic Myelogenous Leukemia (CML)and Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Rouhimoghadam, Milad
    Tang, Hua
    Bates, Briana
    Liao, Junzhuo
    Uribe-Cano, Daniela
    Tang, Weiping
    Deininger, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S336 - S336
  • [9] IMPACT OF ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) ON MINIMAL RESIDUAL DISEASE (MRD) AND BCR-ABL KINASE DOMAIN MUTATIONS IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL)
    Pfeifer, H.
    Wystub, S.
    Wassmann, B.
    Brueck, P.
    Goekbuget, N.
    Wunderle, L.
    Chromik, J.
    Serve, H.
    Hoelzer, D.
    Ottmann, O. G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 368 - 368
  • [10] Activating Mutations Observed in De Novo Acute Myeloid Leukemia Are Also Present in a Subset of Philadelphia Chromosome (Ph)-Positive Leukemia Patients with BCR-ABL1-Independent Resistance to ABL1 Kinase Inhibitors
    Eide, Christopher A.
    Savage, Samantha L.
    Agarwal, Anupriya
    Bottomly, Daniel
    Wilmot, Beth
    McWeeney, Shannon K.
    Kurtz, Stephen E.
    O'Hare, Thomas
    Deininger, Michael W.
    Loriaux, Marc M.
    Tognon, Cristina E.
    Tyner, Jeffrey W.
    Druker, Brian J.
    BLOOD, 2014, 124 (21)
12345